ABCG5 and sitosterolemia: We treated 2 patients with ABCG5 mutations and sitosterolemia with ezetimibe to reduce cholesterol and plant sterol absorption, leading to the normalization of thrombocytopenia, peripheral smear findings, and hemolytic anemia.